Barclays Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $105
Analysts Have Conflicting Sentiments on These Healthcare Companies: PTC Therapeutics (PTCT), Medtronic (MDT) and OptimizeRx (OPRX)
Barclays Remains a Buy on Medtronic (MDT)
Express News | Medtronic PLC : JP Morgan Raises Target Price to $95 From $88
Earnings Preview: Medtronic to Report Financial Results Pre-market on November 19
$Medtronic(MDT.US)$ is scheduled to release its financial results pre-market on November 19 ET. Earnings PreviewAnalysts estimate $Medtronic(MDT.US)$ to post revenue of USD8.27B for 2025Q2, up 3.64%
Sector Update: Health Care